Dioscin suppresses epithelial-mesenchymal transition in gastric cancer by upregulating Cx43 to inhibit the

Yu Kou1, Rentao Zhu2, Feng Gu1

  • 1School of Traditional Chinese Medicine, Faculty of Medicine, Yangzhou University, Yangzhou, 225009, PR China; NATCM Key Laboratory of Syndrome Differentiation and Treatment of Gastric Cancer, Yangzhou, 225009, PR China.

Abstract

Insights

Dioscin, a natural compound, inhibits gastric cancer metastasis by upregulating connexin 43 (Cx43) and enhancing its function, thereby suppressing the VEGFA/PI3K/AKT/mTOR pathway. This study reveals Cx43

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Connexin 43 (Cx43) and its gap junctions (Cx43-GJs) are implicated in cancer metastasis.
  • Dioscin demonstrates anticancer properties, but its mechanism in gastric cancer (GC) regarding Cx43 is unclear.

Purpose of the Study:

  • To investigate the anti-metastatic effects of dioscin on gastric cancer cells.
  • To elucidate the underlying molecular mechanisms involving Cx43 and associated signaling pathways.

Main Methods:

  • Integrated network pharmacology, molecular docking, and dynamics simulations.
  • Utilized in vitro (cell lines, mutants, knockdown) and in vivo (xenograft) models.
  • Assessed proliferation, invasion, migration, epithelial-mesenchymal transition (EMT), and signaling via Western blot, immunofluorescence, and co-immunoprecipitation.

Main Results:

  • Identified the VEGFA/PI3K/AKT/mTOR pathway as crucial in GC malignancy.
  • Dioscin suppressed this pathway by upregulating Cx43 and enhancing gap junction function.
  • Demonstrated that functional Cx43 is essential for dioscin's anti-metastatic efficacy through a dual-barrier mechanism.

Conclusions:

  • Dioscin inhibits GC metastasis by suppressing the VEGFA/PI3K/AKT/mTOR pathway via Cx43.
  • Establishes Cx43 as a critical link between natural compounds and oncogenic pathways in GC.
  • Highlights the non-channel scaffolding function of Cx43 as a therapeutic target for GC.

Related Concept Videos

Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.6K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.3K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.2K